Literature DB >> 24832462

HMG-CoA enzyme inhibitors for prevention of contrast-induced nephropathy.

Alexandros Briasoulis1, Luis Afonso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24832462     DOI： 10.1007/s11239-014-1088-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  3 in total

1.  Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury.

Authors:  Cristina Quintavalle; Danilo Fiore; Francesca De Micco; Gabriella Visconti; Amelia Focaccio; Bruno Golia; Bruno Ricciardelli; Elvira Donnarumma; Antonio Bianco; Maria Assunta Zabatta; Giancarlo Troncone; Antonio Colombo; Carlo Briguori; Gerolama Condorelli
Journal:  Circulation       Date:  2012-11-12       Impact factor: 29.690

2.  The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials.

Authors:  Lucia Barbieri; Monica Verdoia; Alon Schaffer; Matteo Nardin; Paolo Marino; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

3.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.